Lotus Eye Hospital's Unaudited Results for Q2 FY26 Approved; Net Profit Jumps to Rs 61.37 Lakhs
Lotus Eye Hospital and Institute Limited has released its Standalone Unaudited Financial Results for the quarter ended June 30, 2026. The results include a Limited Review Report issued by Statutory Auditors. These financials were approved by the company's Board of Directors during a meeting held on August 10, 2026.The company operates in the single segment of "Eye Care related sales and services."
Financial Performance Snapshot
The unaudited results reflect various financial metrics across different periods, including the quarter ended June 30, 2026, as well as comparisons to March 31, 2026 (Audited) and previous reporting periods.Financial data for Lotus Eye Hospital and Institute Limited is presented below:
| Particulars | June 30, 2026 (Unaudited) (Rs. in lakhs) | March 31, 2026 (Audited) (Rs. in lakhs) | June 30, 2025 (Unaudited) (Rs. in lakhs) | March 31, 2026 (Audited) (Rs. in lakhs) |
|---|---|---|---|---|
| Income: | ||||
| Revenue from operations | 1,705.71 | 1,360.92 | 135169 | 537141 |
| Other income | 21.08 | 4,822 | - | 117.62 |
| Total income | 1,726.79 | 1,409.14 | - | 5,489.03 |
| Expenses: | ||||
| Cost of materials consumed | 26,322 | 19,352 | 23,592 | 852.09 |
| Purchase of stock-in-trade | 254.02 | 21,751 | 184.20 | 813.52 |
| Changes in inventories | (28.08) | 158 | (1.46) | (152) |
| Service expenses | 324.82 | 280.70 | 26,120 | 1,092.60 |
| Employee benefit expense | 364.89 | 325.88 | 284.38 | 1,217.33 |
| Finance costs | 50.65 | 3,313 | 1,176 | 85.92 |
| Depreciation and amortization expense | 163.54 | 110.27 | 81.89 | 374.94 |
| Other expenses | 23,238 | 293.89 | 239.85 | 1,059.10 |
| Total expenses | 1,625.44 | 1,456.48 | 1,297.74 | 5,493.98 |
| Profit/(loss) before exceptional items and tax | 101.35 | (47.34) | 7,271 | (4.95) |
| Exceptional items | (0.33) | (0.79) | 27 | (41) |
| Profit/(loss) before tax | 101.02 | (48.13) | 72.98 | (5.36) |
| Total tax expense | 39.65 | (16.18) | 1,850 | (13.40) |
| Net profit/(loss) for the period | 61.37 | (31.95) | 54.48 | 8.04 |
Other Comprehensive Income and Equity Capital
Total comprehensive income for the period stood at 62.17 lakh rupees. For comparison, the paid up equity share capital is shown across all periods at 2,079.63 lakh rupees.Earnings per equity share (based on Rs 10 face value) as of June 30, 2026, were reported as follows:
- Basic earnings: (0.15) in rupees.
- Diluted earnings: (0.15) in rupees.
Management and Audit Review Notes
The unaudited financial results have been reviewed by the Audit Committee and subsequently approved by the Board of Directors. Statutory Auditors conducted a limited review of these financial outcomes, which were prepared in accordance with Indian Accounting Standard 34 Interim Financial Reporting (Ind AS 34).Exceptional items relate to profit or loss on the sale of property, plant, and equipment. The company has no subsidiaries, associates, or joint ventures, meaning consolidated financial results are not applicable for the current periods.
LOTUSEYE Stock Price Movement
Lotus Eye Hospital and Institute Limited shares settled today after slipping 2.71% to close at ₹115.61. The stock traded on a volume of 13,828 shares, finishing within an intraday range of ₹115.21 to ₹118.55.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.